BG
MYOV

BlackRock Group’s Myovant Sciences Ltd. MYOV Stock Holding History

BlackRock Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.73M Buy
+299,549
New +$3.47M ﹤0.01% 1349

Other funds holding MYOV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock Group's MYOV Position: Q4 2016 in Review

BlackRock Group opened a new position in Myovant Sciences Ltd. (MYOV) in Q4 2016: 299,549 shares worth $3.73M. The stake represents ﹤0.01% of the portfolio and ranks #1349 among its holdings.

52 funds tracked by Wall St. Rank hold MYOV as of Q4 2016.

  • BlackRock Group held 299,549 shares of Myovant Sciences Ltd. worth $3.73M as of Q4 2016.
  • Myovant Sciences Ltd. was a new BlackRock Group position in Q4 2016.
  • Myovant Sciences Ltd. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1349 holding.
  • 52 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.